LIVE. LONG. DC.
Under the leadership of Mayor Muriel Bowser, a public-private group was convened to jointly draft and create a comprehensive strategic plan called LIVE.LONG.DC (LLDC). The strategic plan is aimed at reducing opioid use, misuse and related deaths by 50% by 2020. The LLDC plan covers prevention, treatment, and recovery supports through seven goals with 50 associated strategies.
To read the full plan and see the latest on our progress, click the link below.
OCME Surveillance Reports: Opioid-related Fatal Overdoses
The DC Office of the Chief Medical Examiner (OCME) is reporting the prevalence of fatal opioid overdoses in the District of Columbia. This monthly report contains the most recent data on opioid-related deaths in the District of Columbia. Data presented in this report is based upon accepted cases of either full autopsy or external exams. All manners of fatal opioid overdoses (accident, homicide, suicide, and undetermined) are included in this report. The report compiles data on opioids causing or contributing to the death in fatal drug overdose cases. This report does not include data on drugs detected but not contributing or causing death. This report examines the presence of opioids (heroin, fentanyl, fentanyl analogs, morphine, prescription opioids, and the general category of opiates) in deaths observed at the OCME.
Opioid-related Fatal Overdoses: January 1, 2018, to June 30, 2024 [PDF] *new*
The DC Office of the Chief Medical Examiner (OCME) investigated a total of 2,515 deaths due to the use of opioids from January 1, 2018, through June 30, 2024. This report examines the presence of opioids (heroin, fentanyl, fentanyl analogs, morphine, prescription opioids, and the general category of opiates) in deaths observed at the OCME.
SUDORS Dashboard: Fatal Overdose Data
SUDORS Data Brief, Number 1, June 2022
Christine L. Mattson, PhD, Sagar Kumar, MPH, Lauren J. Tanz, ScD, Priyam Patel, MSPH, Qingwei Luo, MS, and Nicole Davis, PhD
Source: Centers for Disease Control and Prevention (CDC)